Clinical Trials Logo

Clinical Trial Summary

The etiology of cryptogenic organizing pneumonia (COP)was not clear, but previous studies have shown that in some patients, some pathogen could be detected in bronchoalveolar lavage fluid (BALF), and may be one of the causes of COP. This study aimed to screen the pathogenic microorganisms in BALF and lung puncture fluid of the patients with COP through the next-generation sequencing to further clarify the correlation between the incidence of COP and pathogenic microorganisms.


Clinical Trial Description

The cause of cryptogenic organizing pneumonia (COP) was unknown, but studies had shown that certain bacteria, viruses, or specific pathogens could be detected in bronchoalveolar lavage fluid (BALF) in some patients, and these pathogenic microorganisms may be the cause of COP. Specimens were obtained by conventional methods (sputum, blood, BALF or lung puncture fluid) for microbiological detection. Due to the influence of the quality of acquired specimens, specimen preservation and transportation which were influenced by external factors, many patients did not get good test results, which affected the diagnosis and subsequent treatment of patients. Next-generation sequencing (NGS) which could determine hundreds of thousands to millions of DNA molecules in parallel at one time, and efficiently sequence or fragment of pathogenic microorganisms. NGS had greatly improved the detection rate of pathogenic microorganisms. This study aimed to screen pathogenic microorganisms in BALF and lung puncture fluid of COP patients by NGS, and further clarify the correlation between occurrence of COP and pathogenic microorganisms. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04511884
Study type Observational
Source Shanghai Pulmonary Hospital, Shanghai, China
Contact Jin-fu XU, M.D
Phone 8621-65115006
Email jfxucn@163.com
Status Recruiting
Phase
Start date August 7, 2020
Completion date December 2024

See also
  Status Clinical Trial Phase
Recruiting NCT05365802 - FAPI PET for Lung Fibrosis Early Phase 1
Terminated NCT03142191 - A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis Phase 2
Active, not recruiting NCT03747627 - BPF Genetics of ILD Study
Enrolling by invitation NCT04896138 - University of Virginia Natural History Study
Terminated NCT01151527 - Peripheral Blood Biomarkers in Idiopathic Interstitial Pneumonias N/A